Zoonotic Diseases

Diseases discussed here have a history of use as an agent for biological warfare, either in the U.S. or abroad. Its use may have been experimental or actual, and any detrimental consequences upon humans, animals or the environment may have been intentional or not, depending on the circumstances, the point in time, and the nature of the disease.

Saturday, October 9, 2010

African Natives Suffer From Weaponized Disease Epidemic as Plans to Increase Oil Production Move Forward in Gabon

Chikungunya & Dengue EPIDEMIC in OIL RICH Gabon, Africa

Gabon is located in West Central Africa, sharing borders with Equatorial Guinea to the northwest, Cameroon to the north, and with the Republic of the Congo curving around the east and south. The Gulf of Guinea, an arm of the Atlantic Ocean is to the west. It has an estimated population of 1, 500,000 people. Gabon is more prosperous than most nearby countries, with a per capita income four times the average for sub-Saharn Africa. This is in large part due to offshore oil production. There are plans for increased production by the end of the year 2010. Gabon is also rich in uranium deposits. Gabons principal trading partners are the US, China and Russia for exports while importing mainly from France.

On December 5, 2007, JP Morgan acted as Joint-Bookrunner on the Gabonese Republics debut international US1$Billion 10yr bond issue.

More on Gabon; http://en.wikipedia.org/wiki/Gabon

Both of these diseases are normally spread by a certain species of misquito, and have been weaponized over the years by several countries, including the US; (Chikungunya)http://en.wikipedia.org/wiki/Chikungunya
(Dengue) http://en.wikipedia.org/wiki/Dengue_fever
 and now, it has appeared in two more neighboring towns, and by the report in the link below, the authorities are not equipt to combat or control the spread;  (see report in link below)

and the only thing the Health Workers can do for the people is to pass out mosquito nets and school them on mosquito eradication.

No comments:

Post a Comment